Free Trial

Outset Medical (OM) Competitors

Outset Medical logo
$20.90 +0.45 (+2.20%)
Closing price 07/8/2025 04:00 PM Eastern
Extended Trading
$20.86 -0.04 (-0.19%)
As of 04:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OM vs. AORT, CDRE, TNDM, ESTA, LQDA, SSII, FNA, BLFS, PLSE, and KMTS

Should you be buying Outset Medical stock or one of its competitors? The main competitors of Outset Medical include Artivion (AORT), Cadre (CDRE), Tandem Diabetes Care (TNDM), Establishment Labs (ESTA), Liquidia Technologies (LQDA), SS Innovations International (SSII), Paragon 28 (FNA), BioLife Solutions (BLFS), Pulse Biosciences (PLSE), and Kestra Medical Technologies (KMTS). These companies are all part of the "medical equipment" industry.

Outset Medical vs. Its Competitors

Outset Medical (NASDAQ:OM) and Artivion (NYSE:AORT) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, media sentiment, institutional ownership, risk, profitability, analyst recommendations and dividends.

Artivion has a net margin of -5.49% compared to Outset Medical's net margin of -98.74%. Artivion's return on equity of 3.63% beat Outset Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Outset Medical-98.74% -143.62% -37.50%
Artivion -5.49%3.63%1.34%

86.4% of Artivion shares are owned by institutional investors. 2.4% of Outset Medical shares are owned by insiders. Comparatively, 8.1% of Artivion shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Artivion has higher revenue and earnings than Outset Medical. Artivion is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Outset Medical$113.69M3.26-$127.98M-$29.15-0.72
Artivion$388.54M3.36-$13.36M-$0.50-61.18

Outset Medical has a beta of 2.15, meaning that its share price is 115% more volatile than the S&P 500. Comparatively, Artivion has a beta of 1.62, meaning that its share price is 62% more volatile than the S&P 500.

Outset Medical currently has a consensus price target of $27.00, indicating a potential upside of 29.19%. Artivion has a consensus price target of $32.40, indicating a potential upside of 5.92%. Given Outset Medical's higher possible upside, analysts clearly believe Outset Medical is more favorable than Artivion.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Outset Medical
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.00
Artivion
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
3.17

In the previous week, Outset Medical and Outset Medical both had 1 articles in the media. Artivion's average media sentiment score of 1.70 beat Outset Medical's score of 0.37 indicating that Artivion is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Outset Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Artivion
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Summary

Artivion beats Outset Medical on 12 of the 15 factors compared between the two stocks.

Get Outset Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for OM and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OM vs. The Competition

MetricOutset MedicalMEDICAL INFO SYS IndustryMedical SectorNASDAQ Exchange
Market Cap$362.42M$1.97B$5.47B$8.95B
Dividend YieldN/AN/A5.25%4.04%
P/E Ratio-0.7235.7726.9620.11
Price / Sales3.2615.86430.20119.79
Price / CashN/A54.5536.8257.86
Price / Book2.798.567.985.56
Net Income-$127.98M-$62.39M$3.16B$248.40M
7 Day Performance1.55%4.26%2.39%4.67%
1 Month Performance-1.60%4.34%2.18%6.64%
1 Year Performance-64.99%9.18%33.82%21.31%

Outset Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OM
Outset Medical
1.4433 of 5 stars
$20.90
+2.2%
$27.00
+29.2%
-61.2%$362.42M$113.69M-0.72520High Trading Volume
AORT
Artivion
2.7704 of 5 stars
$31.17
-0.1%
$32.00
+2.7%
+19.3%$1.33B$388.54M-62.341,600
CDRE
Cadre
3.5586 of 5 stars
$31.94
-0.3%
$37.50
+17.4%
-7.7%$1.30B$567.56M33.622,284
TNDM
Tandem Diabetes Care
4.2583 of 5 stars
$18.64
-1.6%
$33.43
+79.3%
-60.6%$1.26B$940.20M-6.712,650Positive News
ESTA
Establishment Labs
1.2076 of 5 stars
$42.71
+4.3%
$52.40
+22.7%
-2.2%$1.18B$166.02M-13.781,018
LQDA
Liquidia Technologies
3.1861 of 5 stars
$12.46
-4.9%
$26.89
+115.8%
+2.7%$1.12B$14M-7.8950
SSII
SS Innovations International
N/A$5.89
+2.1%
N/AN/A$1.12B$20.65M0.004Positive News
FNA
Paragon 28
N/A$13.11
+0.1%
$12.75
-2.7%
+91.0%$1.10B$256.18M-17.71343,000High Trading Volume
BLFS
BioLife Solutions
3.0989 of 5 stars
$21.54
+0.2%
$31.17
+44.7%
+10.3%$1.02B$82.25M-74.27440Positive News
High Trading Volume
PLSE
Pulse Biosciences
3.879 of 5 stars
$15.09
+0.1%
N/A+0.1%$1.01B$700K0.00140News Coverage
Positive News
Analyst Forecast
KMTS
Kestra Medical Technologies
N/A$16.58
-6.2%
$27.50
+65.9%
N/A$907.33MN/A0.00300

Related Companies and Tools


This page (NASDAQ:OM) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners